Associations between placental CpG methylation of metastable epialleles and childhood body mass index across ages one, two and ten in the Extremely Low Gestational Age Newborns (ELGAN) cohort

Abstract

The Developmental Origins of Health and Disease (DOHaD) hypothesis posits that <i>in utero</i> and early life conditions can disrupt normal fetal development and program susceptibility to later-life disease. Metastable epialleles are genomic loci in which CpG methylation patterning is responsive to maternal diet and conserved across time and tissues. Thus, these sites could serve as 'signatures' of gestational environment conditions. Here, we sought to determine if methylation of metastable epialleles was associated with changes in childhood body mass index (BMI) z-scores across ages one, two and ten in the Extremely Low Gestational Age Newborns (ELGAN) cohort. CpG methylation of 250 probes (corresponding to 111 genes) within metastable epiallele regions was measured in placental tissue. Linear mixed effects models were fit to evaluate the overall and sex-stratified associations between methylation and changes in BMI z-score over time. In total, 26 probes were associated (<i>p</i> < 0.05) with changes in BMI z-score overall, including probes within Mesoderm Specific Transcript <i>(MEST)</i> and Histone Deacetylase 4 (<i>HDAC4</i>), which have previously been associated with childhood obesity and adipogenesis. Sex-stratified analyses revealed a significant association, after adjusting for multiple comparisons (<i>q</i> < 0.05), within female placentas for one probe annotated to the imprinted gene PLAG1 Like Zinc Finger 1 (<i>PLAGL1)</i>. These findings suggest epigenetic marks may be involved in programming susceptibility to obesity <i>in utero</i> and highlight the potential to use placental tissues in predicting growth rate trajectories among premature infants.